US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 2.1500
- +0.0699+3.36%
Trading Oct 15 10:10 ET
3.44MMarket Cap-179P/E (TTM)
2.1500High2.0800Low6.81KVolume2.0800Open2.0801Pre Close14.31KTurnover0.52%Turnover RatioLossP/E (Static)1.60MShares32.850052wk High0.91P/B2.81MFloat Cap2.070052wk Low--Dividend TTM1.31MShs Float36000.0000Historical High--Div YieldTTM3.37%Amplitude2.0700Historical Low2.1010Avg Price1Lot Size
Alaunos Therapeutics Stock Forum
Sign in to post a comment
$Alaunos Therapeutics (TCRT.US)$ Using "ghost"'shares today to send it down trying to get people to sell until they have shares available tomorrow to cover.
4
1
$Alaunos Therapeutics (TCRT.US)$ July 16th (Eastern Time) - $Alaunos Therapeutics (TCRT.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from July 18th, 2024.
2
$Alaunos Therapeutics (TCRT.US)$ Yes, this has been on a great uptrend! Nice profits have been made! Now going forward its all speculative IMO! So an R/S has been voted on and approved. No date set but expected very soon, if the company actually decides to go through with it? Also Company cut its workforce by 80% to save money! As it stands they had cut one of its pretty successful drug trials ( TCR-T libra...
1
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Alaunos Therapeutics (TCRT.US)$ Alaunos wins bullish view at Wells Fargo on promise of cell therapy technology
2
$Alaunos Therapeutics (TCRT.US)$ TCR-T Library Phase 1/2 trial achievedan 87% disease control rate of eight evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all treated patients
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Salmon Klein : in already master?